Back to the list
Congress: ECR25
Poster Number: C-12115
Type: Poster: EPOS Radiologist (educational)
Authorblock: D. Luengo Gómez, A. J. Lainez Ramos-Bossini, S. Molina Espinoza, Á. Salmerón Ruiz; Granada/ES
Disclosures:
David Luengo Gómez: Nothing to disclose
Antonio Jesus Lainez Ramos-Bossini: Nothing to disclose
Sergio Molina Espinoza: Nothing to disclose
Ángela Salmerón Ruiz: Nothing to disclose
Keywords: Abdomen, Oncology, MR, Observer performance, Radiation effects, Radiation therapy / Oncology, Cancer
References

[1] Fernandes MC, Gollub MJ, et al. The importance of MRI for rectal cancer evaluation. Surg Oncol 2022;43. doi.org/10.1016/J.SURONC.2022.101739.

[2] Jayaprakasam VS, Alvarez J, et al. Watch-and-Wait Approach to Rectal Cancer: The Role of Imaging. Radiology 2023;307. doi.org/10.1148/RADIOL.221529.

[3] Kuo LJ, Chern MC, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005;48:23–8. doi.org/10.1007/S10350-004-0787-5.

[4] Lambregts DMJ, Vandecaveye V, et al. Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study. Ann Surg Oncol 2011;18:2224. doi.org/10.1245/S10434-011-1607-5.

[5] Lahaye MJ, Beets GL, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology 2009;252:81–91. doi.org/10.1148/RADIOL.2521081364.

[6] Zhang Z, Chen Y, et al. MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison. Cancer Imaging 2023;23. doi.org/10.1186/s40644-023-00589-0.

[7]       Ogura A, Konishi T, et al. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. JAMA Surg 2019;154. doi.org/10.1001/JAMASURG.2019.2172.

[8] Fujita S, Mizusawa J, et al. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg 2017;266:201–7. doi.org/10.1097/SLA.0000000000002212.

[9] Maas M, Beets-Tan RGH, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011;29:4633–40. doi.org/10.1200/JCO.2011.37.7176.

[10] Fokas E, Appelt A, et al. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol 2021;18:805–16. doi.org/10.1038/S41571-021-00538-5.

[11] Glynne-Jones R, Wyrwicz L, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28:iv22–40. doi.org/10.1093/ANNONC/MDX224.

[12] Glimelius B, Beets-Tan R, et al. Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol 2011;29:2142–3. doi.org/10.1200/JCO.2010.34.4473.

[13] Smith NJ, Barbachano Y, et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008;95:229–36. doi.org/10.1002/BJS.5917.

[14] Chand M, Swift RI, et al. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer 2014;110:19–25. doi.org/10.1038/BJC.2013.603.

[15] Patel UB, Blomqvist LK, et al. MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience. AJR Am J Roentgenol 2012;199. doi.org/10.2214/AJR.11.8210.

[16] Patel UB, Taylor F, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011;29:3753–60. doi.org/10.1200/JCO.2011.34.9068.

[17] Santiago I, Barata M, et al. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer. Eur Radiol 2020;30:224–38. doi.org/10.1007/s00330-019-06348-9.
GALLERY